Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators.

JAMA. 2003 Dec 3;290(21):2805-16.

PMID:
14657064
2.

Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension.

Muijsers RB, Curran MP, Perry CM.

Drugs. 2002;62(17):2539-67. Review.

PMID:
12421112
3.

Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination.

Sharma SK, Ruggenenti P, Remuzzi G.

Vasc Health Risk Manag. 2007;3(4):453-65. Review.

4.

Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension.

Reynolds NA, Wagstaff AJ, Keam SJ.

Drugs. 2005;65(13):1893-914. Review.

PMID:
16114984
5.

[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].

Oparil S, Bakir SE.

Drugs. 2000;59 Spec No 2:25-37. Review. French.

PMID:
11002856
6.

The fixed combination of verapamil SR/trandolapril.

Widimský J.

Expert Opin Pharmacother. 2000 Mar;1(3):515-35. Review.

PMID:
11249535
7.

Fixed combination verapamil SR/trandolapril.

Dooley M, Goa KL.

Drugs. 1998 Nov;56(5):837-44; discussion 845-6. Review.

PMID:
9829157
8.
9.

Trandolapril: a newer angiotensin-converting enzyme inhibitor.

Guay DR.

Clin Ther. 2003 Mar;25(3):713-75. Review.

PMID:
12852701
10.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Evid Based Child Health. 2014 Sep;9(3):498-580. doi: 10.1002/ebch.1974. Review.

PMID:
25236305
12.

Cochrane in context: pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS.

Evid Based Child Health. 2014 Sep;9(3):581-3. doi: 10.1002/ebch.1975. Review.

PMID:
25236306
13.

Treating essential hypertension. The first choice is usually a thiazide diuretic.

[No authors listed]

Prescrire Int. 2014 Sep;23(152):215-20. Review.

PMID:
25325125
14.

Beta-blockers for hypertension.

Wiysonge CS, Bradley H, Mayosi BM, Maroney R, Mbewu A, Opie LH, Volmink J.

Cochrane Database Syst Rev. 2007 Jan 24;(1):CD002003. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD002003.

PMID:
17253471
15.

Pharmacological interventions for hypertension in children.

Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh R.

Cochrane Database Syst Rev. 2014 Feb 1;(2):CD008117. doi: 10.1002/14651858.CD008117.pub2. Review.

PMID:
24488616
16.

First-line drugs for hypertension.

Wright JM, Musini VM.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001841. doi: 10.1002/14651858.CD001841.pub2. Review.

PMID:
19588327
17.
18.
19.

Trandolapril/verapamil combination in hypertensive diabetic patients.

García Donaire JA, Ruilope LM.

Vasc Health Risk Manag. 2007;3(1):77-82. Review.

20.

Treatment of hypertension in peripheral arterial disease.

Lane DA, Lip GY.

Cochrane Database Syst Rev. 2013 Dec 4;(12):CD003075. doi: 10.1002/14651858.CD003075.pub3. Review.

PMID:
24307487
Items per page

Supplemental Content

Write to the Help Desk